Advertisement

β1,4-Galactosyltransferase Variations in Rheumatoid Arthritis

  • Azita Alavi
  • John Axford
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 376)

Abstract

Evidence indicating an important link between glycosylation changes and autoimmune rheumatic disease is presented. Attention is especially focused on the interrelationship between reduced galactosylation of the oligosaccharides of IgG, auto-sensitization to which is thought to be of central importance in the pathogenesis of rheumatoid arthritis (RA), and the enzyme β 1,4-Galactosyltransferase (GTase) that catalyses the addition of galactose to the oligosaccharide chains on this molecule.

Keywords

Rheumatoid Arthritis Peripheral Lymphocyte Autoimmune Rheumatic Disease Glycosylation Change Galactosyltransferase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Horowitz M. The glycoconjugates. Academic Press, New York 1982; Vol.III. 369pp.Vol.IV 362pp.Google Scholar
  2. 2.
    Bock G and Harnett S. Carbohydrate recognition in cellular function. Ciba Foundation Symposium. John Wiley & Sons Ltd, London. 1989; 249 pp.Google Scholar
  3. 3.
    Neel D, Merlu B, Turpin E, Rabourdin-Combe C, Mach B, Goussault Y and Charron DJ. Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell lines. Biochem J 1987; 244(2): 433–42.PubMedGoogle Scholar
  4. 4.
    Brenner MB, Mclean J, Scheft H, Riberdy J, Ang S, Serdman JG, Devlin P and Krangel MS. Two forms of the T cell receptor protein found on peripheral blood cytotoxic T lymphocytes. Nature 1987; 325: 689.PubMedCrossRefGoogle Scholar
  5. 5.
    Edberg JC, Barinsky M, Radecha PB, Salmon JE and Kimberley RP. Differences in glycosylation between FcgIII expressed on cultured monocytes and NK cells influence the ligand binding site. Arthritis Rheum 1990; 33(9): S108.(Abstr)Google Scholar
  6. 6.
    A Varki. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993; 3 (2): 97–100.PubMedCrossRefGoogle Scholar
  7. 7.
    Roitt IM, Dwek RA, Rademacher TW, Alavi A, Axford JS, Bodman KB, Bond A, Cooke A, Hay FC, Isenberg DA, Lydyard PH, Mackenzie L, Rook G, Smith M and Sumar N. The role of antigen in autoimmune responses with special reference to changes in carbohydrate structure of IgG in rheumatoid arthritis. J. Autoimmun 1988; 1: 499–506.CrossRefGoogle Scholar
  8. 8.
    Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi K, Matsuta K, Takeuchi Y, Nagano T, Myamoto T and Kobata A. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452–457.PubMedCrossRefGoogle Scholar
  9. 9.
    Jefferis R, Lund J & Pound J. Molecular definition of interaction sites on Hu IgG for Fc receptors. Molecular Imm 1990; 27(12); 1237–1240.CrossRefGoogle Scholar
  10. 10.
    Leatherbarrow RJ, Rademacher TW, Dwek RA, Woof JM, Clark A and Burton DR. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement CI and interaction with human monocyte Fc receptor. Mol Immunol. 1985; 22: 406.CrossRefGoogle Scholar
  11. 11.
    Nose M and Wigzell H. Biological significance of carbohydrate chains of monoclonal antibodies. Proc Natl Acad Sci. 1983; 80: 6632–6636.PubMedCrossRefGoogle Scholar
  12. 12.
    Tsuchiya N, Endo T, Matsuta K, Yoshinoya S, Aikawa T, Kosuge E, Takeuchi T, Miyamoto T and Kobata A. Effects of Galactose Depletion from Oligosaccharide Chains on Immunological Activities of Human IgG. J Rheumatol. 1989; 16: 285–290.PubMedGoogle Scholar
  13. 13.
    Newkirk MM, Fournier MJ and Novick JS. Differential clearance of glycoforms of IgG2a contribute to the increase of gal(o) in MRL mice. Glycosylation & Disease 1994; 1(3): 211 4.4Google Scholar
  14. 14.
    Heyman B, Nose M and Weigle WO. Carbohydrate chains of monoclonal antibodies. J Immunol. 1985; 134:4018–4023.PubMedGoogle Scholar
  15. 15.
    Berger EG, Thurnher M and Muller U. Galactosyltransferase and sialyltransferase are located in different subcellular compartments in HeLa cells. Exp Cel Res (EPB) 1987; 173: 267–73.CrossRefGoogle Scholar
  16. 16.
    Shur BD. β1,4 galactosyltransferase: Twenty years later. Glycobiology 1991; 1: 563–575.PubMedCrossRefGoogle Scholar
  17. 17.
    Schachter H and Rodén L. The biosynthesis of animal glycoproteins. In: Metabolic Conjugation and Metabolic Hydrolysis; WH Fishman, Editor; Academic Press, New York. pp 1 –149:Google Scholar
  18. 18.
    McGuire EJ, Kerlin R, Cebra JJ and Roth S. A human milk galactosyltyransferase is specific for secreted, but not plasma IgA. J Immunol 1989; 143(9): 2933–8.PubMedGoogle Scholar
  19. 19.
    Shaper NL, Shaper JH, Bertness V, Chang H, Kirsch IR and Hollis GF. The human galactosyltransferase gene is on chromosome 9 at band p13. Somatic Cell Mol Genet 1986; 12: 633–6.CrossRefGoogle Scholar
  20. 20.
    Russo RN, Shaper NL and Shaper JH. Bovine β1,4 galactosyltransferase: two sets of mRNA transcripts encode two forms of the protein with different amino-terminal domains. In vitro translation experiments demonstrate that both the short and the long forms of the enzyme are type II membrane-bound glycoproteins. J Biol Chem 1990; 265(6): 3324–31.PubMedGoogle Scholar
  21. 21.
    Shur BD and Hall NG. Sperm surface galactosyltransferase activities during in vitro capacitation. J Cell Biol 1982; 95: 567–573.PubMedCrossRefGoogle Scholar
  22. 22.
    Bayna EM, Runyan RB, Scully NF, Reichner J, Lopez LC and Shur BD. Cell surface galactosyltransferase as a recognition molecule during development. Mol Cell Biochem 1986; 72: 141–51.PubMedCrossRefGoogle Scholar
  23. 23.
    Bayna ME, Shaper JH and Shur BD. Temporally specific involvement of cell surface β1,4 galactosyl-transferase during mouse embryo morula compaction. Cell 1988; 53: 145–157.PubMedCrossRefGoogle Scholar
  24. 24.
    Begovac PC and Shur BD. Cell surface galactosyltransferase mediates the initiation of neutite outgrowth from PC12 cells on laminin. J Biol Chem 1990; 110(2): 461–70.Google Scholar
  25. 25.
    Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC and Roitt IM. Reduced B cell galactosyl-transferase activity in rhematoid arthritis. Lancet 1987; 11: 1486–1488.CrossRefGoogle Scholar
  26. 26.
    Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, Roitt IM. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest 1992; 89(3): 1021–1031.PubMedCrossRefGoogle Scholar
  27. 27.
    Gerber AC, Kozdzowski I, Wyss SR, Berger EG. The charge heterogeneity of soluble human galactosyl-transferase isolated from milk, amniotic fluid and malignant ascites. Eur J Biochem 1979; 93: 453–460PubMedCrossRefGoogle Scholar
  28. 28.
    Sumar N, Bodman KB, Rademacher TW, Dwek RA, Williams P, Parekh RB, Edge J, Rook GAW, Isenberg DA, Hay FC and Roitt IM. Analysis of glycosylation changes using lectins. J Imm Method. 1990; 131: 127–136CrossRefGoogle Scholar
  29. 29.
    Alavi A & Axford JS. Anti-Galactosyltransferase Antibody: A potential control mechanism of glycosylation changes in health and disease. J Cellu Biochem 1992: 16D: 152.Google Scholar
  30. 30.
    Dalziel M & Axford JS. RFLP analysis of human b1,4 Galactosyltransferase gene. Non-disease specific Pst.1 polymorphism. Br J Rheumatol 1994: 33: 156 Supplement.Google Scholar
  31. 31.
    Axford JS, Alavi A, Bond A & Hay FC. Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis. Autoimmunity 1994: Vol. 17: 157–163PubMedCrossRefGoogle Scholar
  32. 32.
    Navaratnam N, Virk SS, Ward S, Kuhn NJ. Cationic activation of galactosyltransferase from rat mammary Golgi membranes by polyamines and by basic peptides and proteins. Biochem J 1986; 239: 423–433PubMedGoogle Scholar
  33. 33.
    Imai Y, Yamashita Y, Osawa T. Enhancement of activities of glycosyltransferases involved in the biosynthesis of mucin-type sugar chains in autoimmune MRL-lpr/lpr mouse T cells. Mol Immunol 1988; 25(5): 419–428PubMedCrossRefGoogle Scholar
  34. 34.
    Bond A, Cooke A, Hay FC. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol 1990; 20: 2229–2233PubMedCrossRefGoogle Scholar
  35. 35.
    Soltys AJ, Alavi A & Axford JS. Galactosyltransferase isoenzyme changes occur in rheumatoid arthritis. Arth Rheum (1994) In Press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Azita Alavi
    • 1
  • John Axford
    • 1
  1. 1.Academic Rheumatology Group, Division of ImmunologySt George’s Hospital Medical SchoolLondonUK

Personalised recommendations